A vial label that reads 99% purity and 10 mg looks like it describes 9.9 mg of the target peptide. It usually does not. Purity and content are two separate measurements, made by different methods, describing different things. Confusing them is one of the most common sources of error when a laboratory prepares a solution of known molar concentration. This guide explains what each number means, what it leaves out, and how to combine them.
SOMA Research supplies research-use-only compounds for laboratory use. Nothing here is medical advice.
Two numbers, two questions
| HPLC purity | Net peptide content | |
|---|---|---|
| Answers | Of the peptide material, how much is the target sequence? | Of the powder, how much is peptide at all? |
| Typical method | Reversed-phase HPLC, UV detection at 214–220 nm | Amino acid analysis, nitrogen analysis, or quantitative HPLC against a reference standard |
| Reported as | % of total peak area | % of gross weight, or mg per vial |
| Does not see | Water, counter-ions, salts | Which peptide species make up the peptide fraction |
What HPLC purity measures
In reversed-phase HPLC the sample is separated on a hydrophobic column and a UV detector records absorbance as each species elutes. At 214–220 nm the detector is responding mainly to the peptide bond, so every peptide-like species in the sample produces a peak. Purity is the area of the target peak divided by the total area of all peaks.
That makes HPLC purity a relative figure. It compares the target with other UV-absorbing, peptide-related material. It says nothing about components that do not absorb at that wavelength or that elute in the solvent front, which includes the two things that typically make up most of the non-peptide mass in a lyophilised powder: residual water and counter-ions.
What the impurities usually are
Solid-phase synthesis builds a peptide one residue at a time, and no coupling step is perfectly efficient. The peptide-related impurities that HPLC purity counts against the target are mostly by-products of that process or of later handling:
- Deletion sequences — chains missing one residue because a coupling step failed.
- Truncated sequences — chains that stopped growing early.
- Incompletely deprotected peptides — side-chain protecting groups left in place after cleavage.
- Oxidised forms — most often at methionine, cysteine or tryptophan.
- Deamidated forms — asparagine or glutamine converted to the corresponding acid.
- Diastereomers — a residue racemised during synthesis; the mass is identical, so mass spectrometry cannot see it.
- Dimers and aggregates.
Several of these differ from the target by very little, which is why a purity figure is only as good as the chromatographic method behind it. A shallow gradient that resolves a deletion sequence from the main peak will report a lower, more honest number than a fast gradient that lets the two co-elute. Our HPLC vs mass spectrometry guide covers that limitation in detail.
What net peptide content measures
A lyophilised peptide is not a pure solid of peptide molecules. Basic residues and the N-terminus carry positive charges that are balanced by counter-ions, commonly trifluoroacetate from purification or acetate after salt exchange. The powder also retains bound water that freeze-drying does not remove. Net peptide content is the fraction of the powder’s weight that is actually peptide, of any sequence.
For synthetic peptides this figure commonly falls somewhere between 60% and 90%, and it depends heavily on the sequence: a peptide with many basic residues carries more counter-ion mass than a neutral one. A low net peptide content is not a quality defect. It is a property of the salt form, and it is entirely compatible with a very high HPLC purity.
The classical way to measure it is amino acid analysis: the peptide is hydrolysed, the freed amino acids are quantified, and the total is compared with the weighed mass. Elemental nitrogen analysis and quantitative HPLC against a characterised reference standard are also used. When a certificate reports a measured quantity per vial in milligrams, it is this kind of content determination, not the purity percentage, that the figure comes from.
Putting the two together
The amount of target peptide in a weighed sample is the product of three terms:
target peptide = gross weight × net peptide content × HPLC purity
A worked example for a hypothetical powder:
| Quantity | Value |
|---|---|
| Gross weight of powder | 10.0 mg |
| Net peptide content | 80% |
| HPLC purity | 98% |
| Total peptide (10.0 × 0.80) | 8.0 mg |
| Target peptide (8.0 × 0.98) | 7.84 mg |
A stock solution calculated from the 10.0 mg gross weight would be about 22% less concentrated than intended. In a dose-response experiment that shifts every point on the curve, and it will not reproduce against a second lot with a different net peptide content.
The correction depends on how the quantity is stated. If the certificate reports a gross powder weight, apply both terms. If it reports a measured peptide quantity per vial, the counter-ion and water correction has already been made and only the purity term is left. Read which of the two the certificate is giving before calculating; our Certificate of Analysis guide walks through each field.
How much purity an experiment needs
Peptide manufacturers publish broadly similar guidance on matching purity grade to application. As a general orientation:
| Purity grade | Commonly considered suitable for |
|---|---|
| Crude / desalted | Initial screening, sequence optimisation |
| >70–85% | Antibody production, epitope mapping, semi-quantitative assays |
| >95% | Quantitative in vitro assays, receptor-binding studies, cell-based work |
| >98% | Structural studies such as NMR and crystallography, and work where minor species could confound the result |
The reason higher purity matters for quantitative work is that impurities are not inert. A deletion sequence can retain partial activity at the same receptor, or act as a weak antagonist, and at 5% of the material it can measurably distort a binding curve.
The counter-ion is part of the experiment
Because it is invisible to the purity figure, the counter-ion is easy to forget. It is still in the well. Residual trifluoroacetate has been reported in the literature to affect cell proliferation in culture at concentrations reachable in routine assays, which is one reason acetate or hydrochloride salt forms are often preferred for cell-based work. Where a result is sensitive to this, the salt form belongs in the methods section alongside the purity and the lot number.
What purity does not cover
- Identity. A sample can be 99% pure and be the wrong molecule. That is a mass spectrometry question.
- Endotoxin. Bacterial lipopolysaccharide is measured by a separate LAL assay and is not detected by peptide HPLC.
- Sterility and bioburden. Separate microbiological tests.
- Residual solvents and water. Gas chromatography and Karl Fischer titration respectively.
- Stability after the test date. A purity figure describes the lot on the day it was tested; storage determines what it is later. See peptide storage and stability.
A short checklist
- Is the purity figure accompanied by the chromatogram and the method conditions?
- Is quantity stated as gross weight or as measured peptide content?
- Is identity confirmed by mass spectrometry, with observed and theoretical mass shown together?
- Does the lot number on the certificate match the vial?
- Is the testing laboratory named?
Measured figures for every SOMA lot are published in the CoA library.
Related guides
Research use only
SOMA Research compounds are supplied for laboratory use by qualified researchers and institutions. They are not manufactured to pharmaceutical standards, have not been approved by the FDA for any use, and must not be used in or on humans or animals.
